Literature DB >> 27840018

Presence of Germ Cells in Disorders of Sex Development: Implications for Fertility Potential and Preservation.

Courtney Finlayson1, Michael K Fritsch2, Emilie K Johnson3, Ilina Rosoklija4, Yasmin Gosiengfiao5, Elizabeth Yerkes3, Mary Beth Madonna6, Teresa K Woodruff7, Earl Cheng3.   

Abstract

PURPOSE: We sought to determine the presence of germ cells in the gonads of patients with disorders of sex development to establish whether preservation of germ cells for future fertility potential is possible. We hypothesized that germ cells are present but vary by age and diagnosis.
MATERIALS AND METHODS: We reviewed histology from patients with disorders of sex development who underwent gonadectomy/biopsy from 2002 to 2014 at a single institution for pathological classification of the gonad, composition of gonadal stroma and germ cell presence.
RESULTS: A total of 44 patients were identified and germ cells were present in 68%. The presence and average number of germ cells per mm2 were analyzed by gonad type and diagnosis. By gonad type all ovotestes, most testes, ovaries and dysgenetic testes, and 15% of streak gonads had germ cells present. By diagnosis germ cells were present in all patients with complete androgen insensitivity syndrome, Denys-Drash syndrome, SRY mutation, mixed gonadal dysgenesis, ovotesticular conditions and StAR (steroid acute regulatory protein) deficiency, in some patients with persistent müllerian duct syndrome, XO/XY Turner syndrome and disorders of sex development not otherwise specified, and in none with complete or partial gonadal dysgenesis. Germ cells were present in the gonads of 88% of patients 0 to 3 years old, 50% of those 4 to 11 years old and 43% of those older than 12 years.
CONCLUSIONS: Germ cells were present in the majority of our cohort and the presence decreased with age. This novel, fertility driven evaluation of germ cell quantity in a variety of disorders of sex development suggests that fertility potential may be greater than previously thought. Further studies must be done to evaluate a larger population and examine germ cell quality to determine the viability of these germ cells.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  disorders of sex development; fertility; germ cells; ovary; testis

Mesh:

Year:  2016        PMID: 27840018      PMCID: PMC5309153          DOI: 10.1016/j.juro.2016.08.108

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

1.  Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer.

Authors:  Catherine J Poirot; Hélène Martelli; Catherine Genestie; Jean-Louis Golmard; Dominique Valteau-Couanet; Pierre Helardot; Hélène Pacquement; Frédérique Sauvat; Marie-Dominique Tabone; Pascale Philippe-Chomette; Hélène Esperou; André Baruchel; Laurence Brugieres
Journal:  Pediatr Blood Cancer       Date:  2007-07       Impact factor: 3.167

Review 2.  The emergence of a new interdiscipline: oncofertility.

Authors:  Teresa K Woodruff
Journal:  Cancer Treat Res       Date:  2007

3.  The genetics of disorders of sex development in humans.

Authors:  Thomas Ohnesorg; Eric Vilain; Andrew H Sinclair
Journal:  Sex Dev       Date:  2014-01-31       Impact factor: 1.824

Review 4.  Germline stem cells: toward the regeneration of spermatogenesis.

Authors:  Hanna Valli; Bart T Phillips; Gunapala Shetty; James A Byrne; Amander T Clark; Marvin L Meistrich; Kyle E Orwig
Journal:  Fertil Steril       Date:  2013-12-05       Impact factor: 7.329

Review 5.  Fertility preservation in women with cancer.

Authors:  Michel De Vos; Johan Smitz; Teresa K Woodruff
Journal:  Lancet       Date:  2014-10-04       Impact factor: 79.321

6.  Morphological and histometric study of human spermatogonia from birth to the onset of puberty.

Authors:  R Paniagua; M Nistal
Journal:  J Anat       Date:  1984-10       Impact factor: 2.610

Review 7.  Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care.

Authors:  Peter A Lee; Anna Nordenström; Christopher P Houk; S Faisal Ahmed; Richard Auchus; Arlene Baratz; Katharine Baratz Dalke; Lih-Mei Liao; Karen Lin-Su; Leendert H J Looijenga; Tom Mazur; Heino F L Meyer-Bahlburg; Pierre Mouriquand; Charmian A Quigley; David E Sandberg; Eric Vilain; Selma Witchel
Journal:  Horm Res Paediatr       Date:  2016-01-28       Impact factor: 2.852

Review 8.  Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation.

Authors:  W Hamish B Wallace; Thomas W Kelsey; Richard A Anderson
Journal:  Fertil Steril       Date:  2015-12-08       Impact factor: 7.329

9.  In vitro follicle growth supports human oocyte meiotic maturation.

Authors:  Shuo Xiao; Jiyang Zhang; Megan M Romero; Kristin N Smith; Lonnie D Shea; Teresa K Woodruff
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

10.  The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence.

Authors:  R A Anderson; M McLaughlin; W H B Wallace; D F Albertini; E E Telfer
Journal:  Hum Reprod       Date:  2013-10-17       Impact factor: 6.918

View more
  14 in total

Review 1.  Disorders/differences of sex development (DSDs) for primary care: the approach to the infant with ambiguous genitalia.

Authors:  Justin A Indyk
Journal:  Transl Pediatr       Date:  2017-10

Review 2.  Fertility counseling and preservation: considerations for the pediatric endocrinologist.

Authors:  Amanda J Saraf; Leena Nahata
Journal:  Transl Pediatr       Date:  2017-10

Review 3.  Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium.

Authors:  Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata
Journal:  J Adolesc Health       Date:  2019-01-14       Impact factor: 5.012

4.  Evolving indications for surgical intervention in patients with differences/disorders of sex development: Implications of deferred reconstruction.

Authors:  Erica M Weidler; Gwen Grimsby; Erin M Garvey; Noor Zwayne; Reeti Chawla; Janett Hernandez; Timothy Schaub; Richard Rink; Kathleen van Leeuwen
Journal:  Semin Pediatr Surg       Date:  2020-05-17       Impact factor: 2.754

Review 5.  Disorders of sex development.

Authors:  Selma Feldman Witchel
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2017-11-22       Impact factor: 5.237

6.  The ethics of offering fertility preservation to pediatric patients: A case-based discussion of barriers for clinicians to consider.

Authors:  Erin E Rowell; Timothy B Lautz; Krista Lai; Erica M Weidler; Emilie K Johnson; Courtney Finlayson; Kathleen van Leeuwen
Journal:  Semin Pediatr Surg       Date:  2021-09-04       Impact factor: 1.900

Review 7.  Endocrine Management of Ovotesticular DSD, an Index Case and Review of the Literature.

Authors:  Marissa J Kilberg; Michelle McLoughlin; Louisa C Pyle; Maria G Vogiatzi
Journal:  Pediatr Endocrinol Rev       Date:  2019-12       Impact factor: 1.218

8.  The Ethics of Fertility Preservation for Pediatric Patients With Differences (Disorders) of Sex Development.

Authors:  Lisa Campo-Engelstein; Diane Chen; Arlene B Baratz; Emilie K Johnson; Courtney Finlayson
Journal:  J Endocr Soc       Date:  2017-06-01

Review 9.  FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences?

Authors:  Michael von Wolff; Claus Yding Andersen; Teresa K Woodruff; Frank Nawroth
Journal:  Clin Med Insights Reprod Health       Date:  2019-04-30

Review 10.  Caring for individuals with a difference of sex development (DSD): a Consensus Statement.

Authors:  Martine Cools; Anna Nordenström; Ralitsa Robeva; Joanne Hall; Puck Westerveld; Christa Flück; Birgit Köhler; Marta Berra; Alexander Springer; Katinka Schweizer; Vickie Pasterski
Journal:  Nat Rev Endocrinol       Date:  2018-07       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.